(300 days)
Not Found
No
The summary describes a standard contact lens with a UV blocker and visibility tint. There is no mention of any computational or analytical functions that would suggest the use of AI or ML. The performance studies rely on equivalence to predicate devices and previously submitted clinical data, not on the performance of an AI/ML algorithm.
No
The device is indicated for the correction of refractive ametropia (vision correction) and to block UV radiation (as a UV blocker), which are not considered therapeutic purposes.
No
This device, a contact lens, is indicated for correcting refractive ametropia (myopia or hyperopia with or without astigmatism), which is a treatment for a condition, not a diagnostic tool.
No
The device is a physical contact lens made of hydrogel material, not software.
Based on the provided text, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the correction of refractive ametropia (vision correction) in the eye. This is a therapeutic/corrective function, not a diagnostic one performed on samples taken from the body.
- Device Description: The description details the physical properties and composition of a contact lens, which is a medical device placed on the eye for vision correction.
- Lack of Diagnostic Elements: There is no mention of analyzing samples (blood, urine, tissue, etc.) or providing information for the diagnosis of a disease or condition.
IVD devices are used to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. This contact lens does not fit that description.
N/A
Intended Use / Indications for Use
Discon Plus (Elafilcon A) Contact Lens visibility tint with UV blocker is indicated for daily wear for the correction of refractive ametropia in not-aphakic persons with non-diseased eyes that are myopic or hyperopic and may exhibit refractive astigmatism up to 2.00 diopters that does not interfere with visual acuity.
Eye care practitioners may prescribe the lenses for either single-use daily disposable wear or frequent/planned replacement wear with cleaning, rinsing, disinfection and scheduled replacement as prescribed by the eyecare professional. When prescribed for frequent/planned replacement wear. The contact lens may be disinfected using chemical (not heat) disinfection system.
Product codes
LPL, MVN
Device Description
The Discon Plus (Etafilcon A) Contact Lens visibility tint with UV blocker is available as non-spherical fenses manufactured by spin-casting method. The model illuminated with high water content (58 %). The hydrogel lens' material is a random copolymer composed of 2-hydroxyethyl methacrylate (HEMA) Ind methacrylic acid (MAA), which was cross-linked with 1,1,1-trimethylolpropane trimethacrylate (TMPTMA) and Ethylene Glycol Dimethacrylate (EGDMA) via UV photo- polymerization. The Discon Plus (Etafilcon A) Contact Lens visibility tint with UV blocker is tinted blue using C.I Reactive blue 19 to make the lens more visible for handling In the Discon Plus Contact Lens with UV Blocker, a Benzophenone UV absorbing monomer is used to block UV radiation. The average transmittance characteristics for Discon Plus lens are less than 5% in the UVB range of 280nm - 315nm and less than 30% in the UVA range of 316nm - 380nm. Lenses are supplied sterile in sealed blister packers containing sterile isotonic phosphate buffered saline solution.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Eyes
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Eye care practitioners
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
This 510(k) application describes a UV absorbing compound addition to the predicate device -- Discon (Etafilcon A) Soft (hydrophilic) Contact Lens for Daily Wear cleared via K051129 INNOVA VISION INC. There is no change in the manufacturing process, nor the parameter and properties. The clinical data previously submitted in K051129.supports the clinical safety of the subject device. Besides, the UV absorbing compound and UV-blocking ability are equivalent to ACUVUE (Etafilcon A) Contact Lens clear and visibility tint with UV blocker cleared via K962804 Vistakon. Therefore, no clinical data is required or this submission.
The non-clinical performance tests had been performed to demonstrate the safety and effectiveness of the Discon Plus (Etafilcon A) Contact Lens visibility tint with UV blocker, and establish substantial equivalence to predicate lenses-Discon Lens (K051129); ACUVUE (Etafilcon A) Contact Lens clear and visibility tint with UV blocker (K962804). The evidence of substantial equivalent to the predicate lens described as follow:
- Technological characteristics studies: Compared the new device with predicate devices based on FDA group #, USAN name, production method, %Water content, Refractive index, Oxygen permeability, Power (Diopters), and %Light transmission at different UV/visible ranges.
- Biocompatibility: Toxicology testing (Cytotoxicity, USP Ocular Irritation, USP Systemic Injection) was conducted as recommended by the Premarket Notification guidance document for Daily Wear Contact Lenses, revised May 1994.
- Microbiology: Steam sterilization process validated to deliver a minimum SAL of 10^-6. Shelf-life stability data supports sterility.
- Leachability: Studies conducted showed no leachable monomers and addictive residues at detectable levels.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 886.5925 Soft (hydrophilic) contact lens.
(a)
Identification. A soft (hydrophilic) contact lens is a device intended to be worn directly against the cornea and adjacent limbal and scleral areas of the eye to correct vision conditions or act as a therapeutic bandage. The device is made of various polymer materials the main polymer molecules of which absorb or attract a certain volume (percentage) of water.(b)
Classification. (1) Class II if the device is intended for daily wear only.(2) Class III if the device is intended for extended wear.
(c)
Date PMA or notice of completion of a PDP is required. As of May 28, 1976, an approval under section 515 of the act is required before a device described in paragraph (b)(2) of this section may be commercially distributed. See § 886.3.
0
510 (K) Summary
SUMMARY OF SAFETY AND EFFECTIVENESS FOR Discon Plus (Etafilcon A) Contact Lens visibility tint with UV blocker
| Submitter Information: | SEP - 3 2009 | |
|---|---|---|
| Company: | INNOVA VISION INC. | |
| No. 231-1, Wen-Te Road, Chiung-lin Village, Hsin-Chu County, Taiwan. | ||
| Contact Person: | Mr. Michael w. Hsu, | |
| Executive Vice President | ||
| Phone: | 886-3-592-7299 | |
| FAX: | 886-3-592-6213 | |
| E-Mail: | mikehsu@innovavision.com.tw | |
| Date Prepared | Sept. 20, 2008 |
Identification of Device:
| Classification Name: | Soft hydrophilic contact lens, per 21 CFR. 886.5925 |
|---|---|
| Trade Name: | Discon Plus (Etafilcon A) Contact Lens visibility tint with UV blocker |
| Common or usual Name: | Soft (hydrophilic) Contact lens (daily wear) |
| FDA Classification: | Class II |
Predicate Device:
Discon (Etafilcon A) Soft (hydrophilic) Contact Lens for Daily Wear cleared via K051129 INNOVA VISION INC. Taiwan
ACUVUE (Etafilcon A) Contact Lens clear and visibility tint with UV blocker cleared via K962804 Vistakon, USA
Indications for Use
Discon Plus (Elafilcon A) Contact Lens visibility tint with UV blocker is indicated for daily wear for the correction of refractive ametropia in not-aphakic persons with non-diseased eyes that are myopic or hyperopic and may exhibit refractive astigmatism up to 2.00 diopters that does not interfere with visual acuity.
Eye care practitioners may prescribe the lenses for either single-use daily disposable wear or frequent/planned replacement wear with cleaning, rinsing, disinfection and scheduled replacement as prescribed by the eyecare professional. When prescribed for frequent/planned replacement wear. The contact lens may be disinfected using chemical (not heat) disinfection system.
1
Description of Device
い
・・。
The Discon Plus (Etafilcon A) Contact Lens visibility tint with UV blocker is available as non-spherical fenses manufactured by spin-casting method. The model illuminated with high water content (58 %). `.te hydrogel lens' material is a random copolymer composed of 2-hydroxyethyl methacrylate (HEMA) Ind methacrylic acid (MAA), which was cross-linked with 1,1,1-trimethylolpropane trimethacrylate (TMPTMA) and Ethylene Glycol Dimethacrylate (EGDMA) via UV photo- polymerization. The Discon Plus (Etafilcon A) Contact Lens visibility tint with UV blocker is tinted blue using C.I Reactive blue 19 to make the lens more visible for handling In the Discon Plus Contact Lens with UV Blocker, a Benzophenone UV absorbing monomer is used to block UV radiation. The average transmittance characteristics for Discon Plus lens are less than 5% in the UVB range of 280nm - 315nm and less than 30% in the UVA range of 316nm - 380nm. Lenses are supplied sterile in sealed blister packers containing sterile isotonic phosphate buffered saline solution.
Summary of Clinical Study
This 510(k) application describes a UV absorbing compound addition to the predicate device -- Discon (Etafilcon A) Soft (hydrophilic) Contact Lens for Daily Wear cleared via K051129 INNOVA VISION INC. There is no change in the manufacturing process, nor the parameter and properties. The clinical data previously submitted in K051129.supports the clinical safety of the subject device. Besides, the UV absorbing compound and UV-blocking ability are equivalent to ACUVUE (Etafilcon A) Contact Lens clear and visibility tint with UV blocker cleared via K962804 Vistakon. Therefore, no clinical data is required or this submission.
Nonclinical Studies
All testing was conducted in accordance with the May 1994 FDA guideline titled Premarket Notification 510(K) Guidance Document for Class IV Contact lenses.
The non-clinical performance tests had been performed to demonstrate the safety and effectiveness of the Discon Plus (Etafilcon A) Contact Lens visibility tint with UV blocker, and establish substantial equivalence to predicate lenses-Discon Lens (K051129); ACUVUE (Etafilcon A) Contact Lens clear and visibility tint with UV blocker (K962804). The evidence of substantial equivalent to the predicate lens described as follow:
2
- a) Technological characteristics studies
・・・
The technological characteristics of Discon Plus (Etafilcon A) Contact Lens visibility tint with UV blocker as compared to those of predicate lenses are illustrated in the following table.
| Characteristic | Discon Plus | Discon (K051129) | Acuvue (K962804) |
|---|---|---|---|
| FDA group # | Group # 4 |
50% Water,
Ionic Polymers | Group # 4
50% Water,
Ionic Polymers | Group # 4
50% Water,
Ionic Polymers |
| USAN name | Etafilcon A | Etafilcon A | Etafilcon A |
| Production method | Spin-casting | Spin-casting | Cast-molded |
| %Water content | 58 | 58 | 58 |
| Refractive index | 1.40 | 1.40 | 1.40 |
| Oxygen permeability (edged
corrected) @ 35°C | $24\times10^{-11}$
[(cm²/sec)(ml
O²/ml-mmHg)] | $24\times10^{-11}$
[(cm²/sec)(ml
O²/ml-mmHg)] | $26\times10^{-11}$
[(cm²/sec)(ml
O²/ml-mmHg)] |
| Power, Diopters | +20.0D~-20.0D | +6.0D~-12.0D | +20.0D~-20.0D |
| %Light transmission | | | |
| %T @381700 nm | 93 minimum | 93 minimum | 85 minimum |380 nm | avg ubstantial equivalency, substantiates our ability to manufacture a soft contact lens, the Discon Plus (Etafilcon A) Contact Lens visibility tint with UV blocker, with the same established safety profile and effectiveness as the predicate device-- Discon (Etafilcon A) Soft (hydrophilic) Contact Lens for Daily Wear cleared via K051129 & ACUVUE (Etafilcon A) Contact Lens clear and visibility tint with UV blocker cleared via K962804.
| %T @316
4
Image /page/4/Picture/1 description: The image contains the logo for the Department of Health & Human Services (HHS) in the United States. The logo features the department's emblem, which consists of a stylized caduceus-like symbol with three blue lines representing the three aspects of the department's mission: health, human services, and science. The emblem is encircled by the words "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" in a circular arrangement.
Food and Drug Administration 10903 New Hampshire Avenue Document Mail Center - WO66-G609 Silver Spring, MD 20993-0002
MAR 2 3 2010
Innova Vision, Inc. c/o Harvest Consulting Corp. Ms. Jennifer Reich Senior Consultant 2904 N. Boldt Drive Flagstaff, AZ 86001
Re: K083288
Trade/Device Name: Discon Plus (etafilcon A) Contact Lens visibility tint with UV blocker Regulation Number: 21 CFR 886.5925 Regulation Name: Soft (hydrophilic) Contact Lens Regulatory Class: II Product Code: LPL, MVN Dated: August 12, 2009 Received: August 18, 2009
Dear Ms. Reich:
This letter corrects our substantially equivalent letter of September 3. 2009.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices. good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21
5
CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Sincerely yours,
Kesia Alexander for
Malvina B. Evdelman, M.D. Director Division of Ophthalmic, Neurological, and Ear, Nose and Throat Devices Office of Device Evaluation Center for Devices and Radiological Health
6
INDICATIONS FOR USE STATEMENT
'10(k) Number: K083>88
Device Name: Discon Plus (Etafilcon A) Contact Lens visibility tint with UV blocker
Indications for Use:
Discon Plus (Etafilcon A) Contact Lens visibility tint with UV blocker is indicated for daily wear for the correction of refractive ametropia in not-aphakic persons with non-diseased eyes that are myopic or hyperopic and may exhibit refractive astigmatism up to 2.00 diopters that does not interfere with visual acuity.
Eye care practitioners may prescribe the lenses for either single-use daily disposable wear or frequent/planned replacement wear with cleaning, rinsing, disinfection and scheduled replacement as prescribed by the eyecare professional. When prescribed for frequent/planned replacement wear. The contact lens may be disinfected using chemical (not heat) disinfection system.
Concurrence of CDRH, Office of Device Evaluation (ODE)
| (Division Sign-Off) | |
|---|---|
| Division of Ophthalmic Ear, | |
| Nose and Throat Devices | |
| 510(k) Number | K083288 |
| Prescription Use: | or | Over the Counter Use | ||
|---|---|---|---|---|
| ------------------- | ------------------------------------------- | ---- | ---------------------- | ------------------------------------------- |
| (Division Sign-Off) | |
|---|---|
| Division of Ophthalmic, Neurological and Ear, | |
| Nose and Throat Devices | |
| 510(k) Number | K083288 |